Article

Strategies for Improving the Performance of Prediction Models for Response to Immune Checkpoint Blockade Therapy in Cancer

2023-07-12

Abstract excerpt

Immune checkpoint blockade (ICB) therapy holds promise for bringing long-lasting clinical gains for the treatment of cancer. However, studies show that only a fraction of patients respond to the treatment. In this regard, it is valuable to develop gene expression signatures based on RNA sequencing (RNAseq) data and machine learning methods to predict patients’ response to the ICB therapy, which contributes to more...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 334b26e9-9a05-5aec-9c48-3b155c95ce55
DOI: 10.1101/2023.07.07.23292316

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Strategies for Improving the Performance of Prediction Models for Response to Immune Checkpoint Blockade Therapy in CancerDOI 10.1101/2023.07.07.23292316Read

Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanomaSemantic proximity Read

Predicting Melanoma Immunotherapy Efficacy: Neural Network Models with Gene Expression and Clinical DataSemantic proximity Read

Biological Pathway-Derived TMB Robustly Predicts the Outcome of Immune Checkpoint Blockade Therapy.Semantic proximity Read

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanomaSemantic proximity Read

Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic featuresSemantic proximity Read

Improved prediction of immune checkpoint blockade efficacy across multiple cancer types.Semantic proximity Read

Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients.Semantic proximity Read

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.Semantic proximity Read

Transcriptional analysis of immune modulatory genes in melanoma treated with PD-1 blockadeSemantic proximity Read

Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic featuresSemantic proximity Read

Immunogenic cell death signatures derived from on-treatment tumor specimens for predicting immune checkpoint blockade therapy response and prognosis in metastatic melanomaSemantic proximity Read

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanomaSemantic proximity Read